Company profile for Biocon

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
Hosur Road,Electronics City,Bangalore
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI China

Not Confirmed

envelop Contact Supplier

CPhI China

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets
With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 1138

https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

Radio Compass
06 May 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel highlights Pfanstiehl's portfolio, featuring highest-purity, low-endotoxin injectable-grade excipients, generic APIs and intermediates, HPAPIs, and modified carbohydrates. The company provides API custom synthesis and ADC linker manufacturing services, all backed by USFDA certification.

Impressions: 348

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks
The pharmaceutical excipients market saw significant strategic consolidations, technological developments, and regulatory adaptations in 2025. Globally, the pharmaceutical excipients sector is growing at a compound annual growth rate of 6.6 percent, and was valued at US$ 8.85 billion in 2024. It is projected to reach US$ 14.77 billion by 2032.This year, the sector is witnessing technological advancements, regulatory evolution, and strategic business realignments. North America continues to dominate the global excipients landscape, with a 39.8 percent market share. The Asia-Pacific region is the fastest-growing segment with a substantial 30.4 percent market share, driven by increasing investments in pharmaceutical manufacturing, growing demand for cost-effective drugs, and rising healthcare expenditure across developing economies.Major excipient providers include BASF, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, DuPont, Evonik, Seqens, Actylis, SPI Pharma, PMC Isochem, Croda International, Pfanstiehl, Kewpie Corporation, Boai NKY Pharmaceuticals, ICE Pharma, Roquette, Nanjing Well Pharmaceutical, Minakem, Ashland Global, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)Roquette restructures after buying IFF Pharma; Colorcon partners ASHA CelluloseIn May, Roquette completed its acquisition of IFF Pharma Solutions. Valued at up to US$ 2.85 billion in enterprise value, this transaction represents a major consolidation in the pharmaceutical excipients market. The acquisition significantly enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide. Roquette announced a comprehensive, new organizational structure following the acquisition, indicating the company’s commitment to integrate IFF Pharma Solutions’ capabilities seamlessly into its existing operations. This consolidation creates a more robust platform for addressing the growing demand for specialized excipients in complex drug formulations, particularly as the industry moves towards more personalized approaches to medicines.So far, the year has also witnessed some strategic alliances, such as Colorcon’s partnership with ASHA Cellulose. As part of the deal, Colorcon will become the exclusive representative for two ASHA products — ASHACEL and ASHAKOTE — throughout Europe, the Middle East, Africa, Northeast Asia and Southeast Asia.Brenntag Specialties has announced an exclusive distribution agreement with MEGGLE Excipients to expand market reach. This collaboration makes available a broad portfolio of over 30 high-quality lactose-based excipients for various applications in the pharmaceutical industries across the Netherlands, Belgium, Norway, Finland, and Sweden.The portfolio’s versatility offers optimal solutions for a wide range of pharmaceutical applications, including tableting through both granulation and direct compression, powder preparations, and dry powder inhalation. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)WHO, FDA drive new standards with GMP guidelines; Pfanstiehl launches injectable-grade glycineIn March, the World Health Organization had put out a publication titled “Good Manufacturing Practices for Excipients used in Pharmaceutical Products.” WHO’s excipient GMP guideline emphasizes modern quality management principles, comprehensive risk assessment protocols, and supplier qualification procedures for excipients across all stages of production, storage, and distribution.Meanwhile, the US Food and Drug Administration (FDA) has proposed amendments to the Food, Drug, and Cosmetic Act as part of its FY 2025 legislative proposals, specifically targeting supply chain transparency for high-risk excipients. The FDA proposal would require certain excipients designated as high-risk to carry labeling that identifies the original manufacturer’s name and address. This initiative addresses what FDA has identified as a lack of transparency in excipient supply chains.In April, IFF Pharma Solutions launched Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC). This innovative product is specifically designed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages, addressing one of the most pressing concerns in contemporary pharmaceutical manufacturing.Pfanstiehl, a global leader in high-purity excipient manufacturing, announced the launch of its High Purity Low Endotoxin Low Metals (HPLE-LM) injectable-grade glycine. This multi-compendial glycine is specifically engineered for use in biologics, vaccines, and the downstream purification of monoclonal antibodies (mAbs). Manufactured under ICH-Q7 cGMP regulations at Pfanstiehl’s advanced facility in Waukegan, Illinois, the product meets stringent global pharmacopeial standards. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)Shin-Etsu Chemical invests in Japan, Germany to expand cellulose productionIn March, Shin-Etsu Chemical announced investments in pharmaceutical cellulose business operations in Japan and Europe, thereby showing significant commitment to market expansion. The company is making substantial investments at two key bases: the subsidiary SE Tylose GmbH in Germany, and the Naoetsu Plant in Joetsu, Japan. In Germany, a new production facility for the pharmaceutical excipient L-HPC will be built adjacent to the existing facility, creating a dual base with the Naoetsu Plant. The excipients market in 2025 has seen innovation in functional applications. Research on BENEO’s Palatinose as a bedtime drink shows that it improves aspects of sleep and represents an innovative approach to excipient functionality. Palatinose is a naturally sourced, smart carbohydrate that provides full carbohydrate energy in a more balanced way, thanks to its low-glycemic profile.Gangwal Healthcare, with its EXCiPACT-certified GMP facilities and a robust portfolio of co-processed excipients like ProBlend, Starlose, and Microlose, is actively contributing to the pharmaceutical industry’s demand for functional excipients. The company also offers cellulose-based excipients such as Solvostar (Sodium Starch Glycolate) and Sallyso (Croscarmellose Sodium), designed to improve tablet disintegration and drug release profiles in oral solid dosage forms.Evonik announced a partnership with South Korea–based CDMO ST Pharm to expand its RNA and nucleic acid delivery services. This collaboration enables Evonik to integrate customized nucleic acids from ST Pharm seamlessly with its lipid and lipid nanoparticle (LNP) development and fill-and-finish services. This streamlined approach means that pharmaceutical companies can reduce complexity and increase speed-to-market for nucleic acid therapeutics. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)Our viewThe pharmaceutical excipients market in 2025 is being shaped by several key trends including the development of multifunctional excipients that can simultaneously improve solubility, bioavailability, and control drug release in increasingly complex formulations.Moreover, the expanding generic medicines market is creating demand for cost-effective, versatile excipients. The growing importance of biologics and biosimilars is driving innovation in specialized excipients designed to maintain the stability and efficacy of these complex therapeutic products throughout their lifecycle. And nanotechnology continues to enable advanced nano-excipients for enhanced drug delivery and efficacy.In addition to these trends, we also notice a shift towards natural and plant-based excipients that is driven by sustainability concerns and potential biocompatibility benefits. 

Impressions: 1633

https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks

#PharmaFlow by PHARMACOMPASS
29 May 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/diagnostic-center/biocon-gets-approval-for-diabetes-drug-liraglutide-in-india-17237

INDPHARMAPOST
02 Jun 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218107

FDA
14 May 2025

https://www.indianpharmapost.com/news/biocon-q4-fy25-consolidated-pat-jumps-153-to-rs-344-cr-17149

INDPHARMAPOST
14 May 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/indian-pharma-stocks-decline-after-trump-again-threatens-tariffs-2025-04-09/https://www.reuters.com/business/healthcare-pharmaceuticals/indian-pharma-stocks-decline-after-trump-again-threatens-tariffs-2025-04-09/

REUTERS
09 Apr 2025

https://www.expresspharma.in/biocon-academy-conducts-its-9th-graduation-day/

EXPRESSPHARMA
04 Mar 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-betting-big-on-new-product-launches-for-growth/articleshow/118140110.cms

ECONOMICTIMES
13 Feb 2025

01

Pravastatin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Pravastatin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

02

Atorvastatin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Atorvastatin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

03

Fluvastatin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Fluvastatin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

04

Pravastatin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Pravastatin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCInactive-api NDC KDMF arrow-down VMF Others AUDIT
blank

05

Repaglinide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Repaglinide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCInactive-api NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

06

Everolimus

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Everolimus

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

07

Fingolimod Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Fingolimod Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

08

Micafungin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Micafungin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

09

Pioglitazone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Pioglitazone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC KDMF arrow-down VMF Others AUDIT
blank

10

Sitagliptin Phosphate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

Sitagliptin Phosphate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IOPC
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

02

IOPC
Not Confirmed
arrow

10

IOPC
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more

02

Deferasirox

CEP/COS

IOPC
Not Confirmed
arrow

05

IOPC
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 229MF10178

Registrant's Address : 20th KM Hosur Road, Electronics City, Bengaluru-560 100, Karnataka, India.

Initial Date of Registration : 2017-09-15

Latest Date of Registration : 2023-08-02

blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 223MF10033

Registrant's Address : 20th KM, Hosur Road, Electronics City-560100, Bengaluru, India

Initial Date of Registration : 2011-03-03

Latest Date of Registration : 2011-03-03

blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 225MF10102

Registrant's Address : 20th K. M. Hosur Road, Electronics City-560100, Bangalore, India

Initial Date of Registration : 2013-05-13

Latest Date of Registration : 2015-06-18

blank

04

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 226MF10213

Registrant's Address : Biocon House, Ground Floor, Tower-3, Semicon Park, Electronic City, Phase-II, Hosur R...

Initial Date of Registration : 2014-11-17

Latest Date of Registration : 2019-01-24

blank

05

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 230MF10166

Registrant's Address : 20th KM, Hosur Road, Electronics City-560100, Bengaluru, India

Initial Date of Registration : 2018-12-10

Latest Date of Registration : 2021-01-20

blank

06

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 223MF10039

Registrant's Address : 20th K. M. Hosur Road, Electronics City-560100, Bangalore, India

Initial Date of Registration : 2011-03-10

Latest Date of Registration : 2011-03-10

blank

07

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 223MF10038

Registrant's Address : 20th KM Hosur Road, Electronics City, Bengaluru-560 100, Karnataka, India.

Initial Date of Registration : 2011-03-10

Latest Date of Registration : 2018-03-30

blank

08

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 231MF10044

Registrant's Address : 20th KM, Hosur Road, Electronics City-560100, Bengaluru, India

Initial Date of Registration : 2019-02-13

Latest Date of Registration : 2019-02-13

blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registration Number : 304MF10035

Registrant's Address : 20th K. M. Hosur Road, Electronics City, Bengaluru - 560100, India

Initial Date of Registration : 2022-02-17

Latest Date of Registration : 2022-02-17

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

IOPC
Not Confirmed
arrow

02

IOPC
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-more

01

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Sungwoo Chemical Co., Ltd.

Registration Date : 2019-03-14

Registration Number : 20160429-132-H-300-36(4)

Manufacturer Name : Biocon Limited(Site-2)

Manufacturer Address : Biocon Special Economic zone, Plot Nos. 2, 3, 4 & 5, Phase IV, Bommasandra-Jigani Lin...

blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Pharmasolution Co., Ltd.

Registration Date : 2018-02-08

Registration Number : 20160429-132-H-300-36(3)

Manufacturer Name : Biocon Limited(Site-2)

Manufacturer Address : Biocon Special Economic zone, Plot Nos. 2, 3, 4 & 5, Phase IV, Bommasandra-Jigani Lin...

blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2019-05-24

Registration Number : 20160429-132-H-300-36(5)

Manufacturer Name : Biocon Limited(Site-2)

Manufacturer Address : Biocon Special Economic zone, Plot Nos. 2, 3, 4 & 5, Phase IV, Bommasandra-Jigani Lin...

blank

04

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Seongi Bio Co., Ltd.

Registration Date : 2016-04-29

Registration Number : 20160429-132-H-300-36

Manufacturer Name : Biocon Limited(Site-2)

Manufacturer Address : Biocon Special Economic zone, Plot Nos. 2, 3, 4 & 5, Phase IV, Bommasandra-Jigani Lin...

blank

05

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Iksoo Pharmaceutical Co., Ltd.

Registration Date : 2021-10-25

Registration Number : 20211025-209-J-839

Manufacturer Name : Biocon Limited@Microtrol Steri...

Manufacturer Address : Plot No. 213 – 215 and 216/B, Phase - II, IDA, Pashamylaram, Sangareddy District-50...

blank

06

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Bansen Co., Ltd.

Registration Date : 2020-07-14

Registration Number : Su720-4-ND

Manufacturer Name : Biocon Limited

Manufacturer Address : Plot No. 213 – 215 and 216/B Phase – II, IDA, Pashamylaram, Sangareddy District-5...

blank

07

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2019-04-23

Registration Number : Su207-40-ND

Manufacturer Name : Biocon Limited

Manufacturer Address : Plot No. 213–215 and 216/B, Phase-II, IDA, Pashamylaram, Sangareddy District-502 30...

blank

08

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2021-01-20

Registration Number : 207-47-ND

Manufacturer Name : Biocon Limited

Manufacturer Address : Plot No. 213 – 215 and 216/B, Phase - II, IDA, Pashamylaram, Sangareddy District-50...

blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Aging Life Science Co., Ltd.

Registration Date : 2023-10-06

Registration Number : 434-61-ND

Manufacturer Name : Biocon Limited (Unit-5)

Manufacturer Address : Plot No. 2, Road No. 21 JN Pharma City, Thadi VillageIDA Paravada, Visakhapatnam Andh...

blank

10

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

Registrant Name : Kwangdong Pharmaceutical Co., Ltd.

Registration Date : 2018-09-13

Registration Number : Su30-2-ND(1)

Manufacturer Name : Biocon Limited

Manufacturer Address : Plot No. 2,3,4 & 5, Phase-IV, Bommasandra Jigani Link Road, Bommasandra Post Bengalur...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-072

Start Marketing Date : 2016-08-11

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-081

Start Marketing Date : 2021-08-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-004

Start Marketing Date : 2005-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-033

Start Marketing Date : 2014-11-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-091

Start Marketing Date : 2023-07-24

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-073

Start Marketing Date : 2017-07-02

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-092

Start Marketing Date : 2024-03-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-088

Start Marketing Date : 2017-11-17

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-037

Start Marketing Date : 2017-02-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

NDC Package Code : 65727-085

Start Marketing Date : 2021-12-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view

LISTED APIs

read-more
read-more
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

01

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

04

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

05

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

06

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

07

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

08

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and aut...
The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.
blank

10

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Biocon

The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.

About the Company : The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest a...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Victoza-Generic (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.


Lead Product(s): Liraglutide

Therapeutic Area: Endocrinology Brand Name: Victoza-Generic

Study Phase: Approved FDFProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 02, 2025

blank

01

Biocon

India
arrow
IOPC
Not Confirmed

Biocon

India
arrow
IOPC
Not Confirmed

Details : Victoza-Generic (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.

Product Name : Victoza-Generic

Product Type : Peptide

Upfront Cash : Inapplicable

June 02, 2025

blank

Details:

Yesintek (ustekinumab) is a human interleukin-12 and -23 antagonist indicated for the treatment of adult patients plaque psoriasis and active psoriatic arthritis.


Lead Product(s): Ustekinumab

Therapeutic Area: Dermatology Brand Name: Yesintek

Study Phase: Approved FDFProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 26, 2025

blank

02

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Yesintek (ustekinumab) is a human interleukin-12 and -23 antagonist indicated for the treatment of adult patients plaque psoriasis and active psoriatic arthritis.

Product Name : Yesintek

Product Type : Antibody

Upfront Cash : Inapplicable

May 26, 2025

blank

Details:

Yesintek (ustekinumab) is a human interleukin-12 and -23 antagonist indicated for the treatment of adult patients plaque psoriasis and active psoriatic arthritis.


Lead Product(s): Ustekinumab

Therapeutic Area: Dermatology Brand Name: Yesintek

Study Phase: Approved FDFProduct Type: Antibody

Sponsor: Yoshindo

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 21, 2025

blank

03

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Yesintek (ustekinumab) is a human interleukin-12 and -23 antagonist indicated for the treatment of adult patients plaque psoriasis and active psoriatic arthritis.

Product Name : Yesintek

Product Type : Antibody

Upfront Cash : Inapplicable

May 21, 2025

blank

Details:

Vevzuo (denosumab) is a human monoclonal antibody and a biosimilar candidate to Prolia. It is a RANK ligand inhibitor, which is indicated for postmenopausal osteoporosis.


Lead Product(s): Denosumab

Therapeutic Area: Musculoskeletal Brand Name: Vevzuo

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 28, 2025

blank

04

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Vevzuo (denosumab) is a human monoclonal antibody and a biosimilar candidate to Prolia. It is a RANK ligand inhibitor, which is indicated for postmenopausal osteoporosis.

Product Name : Vevzuo

Product Type : Antibody

Upfront Cash : Inapplicable

April 28, 2025

blank

Details:

Jobevne (bevacizumab) is a biosimilar humanized monoclonal antibody that binds and inhibits VEGF, for the treatment for colorectal cancers.


Lead Product(s): Bevacizumab

Therapeutic Area: Oncology Brand Name: Jobevne

Study Phase: Approved FDFProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 10, 2025

blank

05

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Jobevne (bevacizumab) is a biosimilar humanized monoclonal antibody that binds and inhibits VEGF, for the treatment for colorectal cancers.

Product Name : Jobevne

Product Type : Antibody

Upfront Cash : Inapplicable

April 10, 2025

blank

Details:

Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.


Lead Product(s): Ustekinumab

Therapeutic Area: Dermatology Brand Name: Yesintek

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 07, 2025

blank

06

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.

Product Name : Yesintek

Product Type : Antibody

Upfront Cash : Inapplicable

March 07, 2025

blank

Details:

gVictoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.


Lead Product(s): Liraglutide

Therapeutic Area: Endocrinology Brand Name: Liraglutide Biocon

Study Phase: Approved FDFProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 27, 2025

blank

07

Biocon

India
arrow
IOPC
Not Confirmed

Biocon

India
arrow
IOPC
Not Confirmed

Details : gVictoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.

Product Name : Liraglutide Biocon

Product Type : Peptide

Upfront Cash : Inapplicable

February 27, 2025

blank

Details:

Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.


Lead Product(s): Ustekinumab

Therapeutic Area: Dermatology Brand Name: Yesintek

Study Phase: Approved FDFProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 24, 2025

blank

08

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.

Product Name : Yesintek

Product Type : Antibody

Upfront Cash : Inapplicable

February 24, 2025

blank

Details:

Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.


Lead Product(s): Ustekinumab

Therapeutic Area: Dermatology Brand Name: Yesintek

Study Phase: Approved FDFProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 21, 2025

blank

09

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.

Product Name : Yesintek

Product Type : Antibody

Upfront Cash : Inapplicable

February 21, 2025

blank

Details:

Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.


Lead Product(s): Ustekinumab

Therapeutic Area: Dermatology Brand Name: Yesintek

Study Phase: Approved FDFProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 07, 2025

blank

10

IOPC
Not Confirmed
IOPC
Not Confirmed

Details : Yesintek (ustekinumab), is an approved IL-12/IL-23 inhibitor is given once in 12 weeks SC and IV for the treatment of moderate to severe plaque psoriasis in patients with 6 years or older.

Product Name : Yesintek

Product Type : Antibody

Upfront Cash : Inapplicable

January 07, 2025

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : YESAFILI

IOPC
Not Confirmed
arrow

Brand Name : YESAFILI

arrow
IOPC
Not Confirmed

Biocon Biologics

Dosage Form : INJECTABLE;INJECTION

Brand Name : YESAFILI

Dosage Strength : 2MG(0.05ML,40MG/ML)

Packaging :

Approval Date :

Application Number : 761274

Regulatory Info :

Registration Country : USA

blank

02

Brand Name : ATORVASTATIN CALCIUM

IOPC
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2022-11-23

Application Number : 216436

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : ATORVASTATIN CALCIUM

IOPC
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 80MG BASE

Packaging :

Approval Date : 2022-11-23

Application Number : 216436

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : ATORVASTATIN CALCIUM

IOPC
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2022-11-23

Application Number : 216436

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : ATORVASTATIN CALCIUM

IOPC
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 40MG BASE

Packaging :

Approval Date : 2022-11-23

Application Number : 216436

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : JOBEVNE

IOPC
Not Confirmed
arrow

Brand Name : JOBEVNE

arrow
IOPC
Not Confirmed

Biocon Biologics

Dosage Form : INJECTABLE;INJECTION

Brand Name : JOBEVNE

Dosage Strength : 400MG/16ML

Packaging :

Approval Date :

Application Number : 761175

Regulatory Info :

Registration Country : USA

blank

07

Brand Name : JOBEVNE

IOPC
Not Confirmed
arrow

Brand Name : JOBEVNE

arrow
IOPC
Not Confirmed

Biocon Biologics

Dosage Form : INJECTABLE;INJECTION

Brand Name : JOBEVNE

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 761175

Regulatory Info :

Registration Country : USA

blank

08

Brand Name : DAPTOMYCIN

IOPC
Not Confirmed
arrow

Brand Name : DAPTOMYCIN

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : POWDER;INTRAVENOUS

Brand Name : DAPTOMYCIN

Dosage Strength : 500MG/VIAL

Packaging :

Approval Date : 2024-08-29

Application Number : 217215

Regulatory Info : RX

Registration Country : USA

blank

09

Brand Name : DASATINIB

IOPC
Not Confirmed
arrow

Brand Name : DASATINIB

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : TABLET;ORAL

Brand Name : DASATINIB

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-03-03

Application Number : 217217

Regulatory Info : RX

Registration Country : USA

blank

10

Brand Name : DASATINIB

IOPC
Not Confirmed
arrow

Brand Name : DASATINIB

arrow
IOPC
Not Confirmed

Biocon

Dosage Form : TABLET;ORAL

Brand Name : DASATINIB

Dosage Strength : 80MG

Packaging :

Approval Date : 2025-03-03

Application Number : 217217

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Biocon and get a quotation

Biocon is a supplier offers 85 products (APIs, Excipients or Intermediates).

Find a price of Pravastatin bulk with DMF, CEP, JDMF, WC offered by Biocon

Find a price of Atorvastatin bulk with CEP, JDMF, WC offered by Biocon

Find a price of Fluvastatin Sodium bulk with DMF, CEP, JDMF offered by Biocon

Find a price of Pravastatin bulk with DMF, CEP, JDMF offered by Biocon

Find a price of Repaglinide bulk with DMF, CEP, JDMF offered by Biocon

Find a price of Everolimus bulk with DMF, CEP, WC offered by Biocon

Find a price of Fingolimod Hydrochloride bulk with DMF, CEP, WC offered by Biocon

Find a price of Micafungin bulk with DMF, JDMF, WC offered by Biocon

Find a price of Pioglitazone Hydrochloride bulk with DMF, CEP, WC offered by Biocon

Find a price of Sitagliptin Phosphate bulk with DMF, CEP, WC offered by Biocon

Find a price of Vildagliptin bulk with DMF, JDMF, WC offered by Biocon

Find a price of Deferasirox bulk with DMF, CEP offered by Biocon

Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Biocon

Find a price of Mycophenolate Sodium bulk with DMF, CEP offered by Biocon

Find a price of Rosuvastatin Calcium bulk with DMF, CEP offered by Biocon

Find a price of Simvastatin bulk with DMF, CEP offered by Biocon

Find a price of Simvastatin bulk with CEP, WC offered by Biocon

Find a price of Tacrolimus bulk with DMF, CEP offered by Biocon

Find a price of Atorvastatin bulk with DMF, WC offered by Biocon

Find a price of Everolimus bulk with DMF, CEP offered by Biocon

Find a price of Fluvastatin Sodium bulk with DMF, CEP offered by Biocon

Find a price of Insulin Glargine bulk with DMF, JDMF offered by Biocon

Find a price of Mirabegron bulk with DMF, WC offered by Biocon

Find a price of Pioglitazone Hydrochloride bulk with DMF, CEP offered by Biocon

Find a price of Rivaroxaban bulk with DMF, CEP offered by Biocon

Find a price of Sitagliptin Hydrochloride bulk with DMF, WC offered by Biocon

Find a price of Temsirolimus bulk with DMF, WC offered by Biocon

Find a price of Teriflunomide bulk with DMF, CEP offered by Biocon

Find a price of Apixaban bulk with DMF offered by Biocon

Find a price of Atorvastatin bulk with WC offered by Biocon

Find a price of Brinzolamide bulk with DMF offered by Biocon

Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Biocon

Find a price of Dapagliflozin bulk with DMF offered by Biocon

Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Biocon

Find a price of Dasatinib bulk with DMF offered by Biocon

Find a price of Lenalidomide bulk with DMF offered by Biocon

Find a price of Linagliptin bulk with DMF offered by Biocon

Find a price of Lovastatin bulk with DMF offered by Biocon

Find a price of Mycophenolate Mofetil bulk with CEP offered by Biocon

Find a price of Orlistat bulk with WC offered by Biocon

Find a price of Pimecrolimus bulk with DMF offered by Biocon

Find a price of Posaconazole bulk with DMF offered by Biocon

Find a price of Sirolimus bulk with DMF offered by Biocon

Find a price of Anidulafungin bulk with DMF offered by Biocon

Find a price of Boron bulk with JDMF offered by Biocon

Find a price of Cabozantinib bulk with DMF offered by Biocon

Find a price of Empagliflozin bulk with DMF offered by Biocon

Find a price of Fidaxomicin bulk with WC offered by Biocon

Find a price of Fluvastatin Sodium bulk with CEP offered by Biocon

Find a price of Hydroxy Echinocandin bulk with DMF offered by Biocon

Find a price of Insulin Lispro bulk with DMF offered by Biocon

Find a price of Ivacaftor bulk with DMF offered by Biocon

Find a price of Liraglutide bulk with DMF offered by Biocon

Find a price of Lovastatin bulk offered by Biocon

Find a price of Lurasidone Hydrochloride bulk with DMF offered by Biocon

Find a price of Mevastatin bulk with DMF offered by Biocon

Find a price of Nintedanib Esylate bulk with DMF offered by Biocon

Find a price of Olaparib bulk with DMF offered by Biocon

Find a price of Orlistat bulk with DMF offered by Biocon

Find a price of Sacubitril Sodium bulk with DMF offered by Biocon

Find a price of Semaglutide bulk with DMF offered by Biocon

Find a price of Sitagliptin Hydrochloride bulk with DMF offered by Biocon

Find a price of Sitagliptin Phosphate bulk with DMF offered by Biocon

Find a price of Tacrolimus bulk with DMF offered by Biocon

Find a price of Tacrolimus bulk offered by Biocon

Find a price of Travoprost bulk with DMF offered by Biocon

Find a price of Valsartan bulk with DMF offered by Biocon

Find a price of TICAGRELOR PH. EUR bulk with DMF offered by Biocon

Find a price of Atorvastatin bulk offered by Biocon

Find a price of Glatiramer Acetate bulk offered by Biocon

Find a price of Heparin Sodium bulk offered by Biocon

Find a price of Insulin Lispro bulk offered by Biocon

Find a price of Ivabradine Hydrochloride bulk offered by Biocon

Find a price of Mycophenolate Sodium bulk offered by Biocon

Find a price of Mycophenolic Acid bulk offered by Biocon

Find a price of Papain bulk offered by Biocon

Find a price of Rosiglitazone Maleate bulk offered by Biocon

Find a price of Simvastatin bulk offered by Biocon

Find a price of Vildagliptin bulk offered by Biocon

Find a price of CAS 654671-77-9 bulk offered by Biocon

Find a price of Fluvastatin bulk offered by Biocon

Find a price of Lenalidomide bulk offered by Biocon

Find a price of Liraglutide bulk offered by Biocon

Find a price of Mycophenolate Mofetil bulk offered by Biocon

Find a price of Rosuvastatin Calcium bulk offered by Biocon

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty